Patent Application
Utility
App. No. 17/215,686
· Confirmation No. 9729
Systems And Methods Of Administering A Pharmaceutical Gas To A Patient
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-08-14 | OATH |
Oath or Declaration filed | 75 | View | |
| 2024-09-06 | ABN |
Abandonment | 2 | View | |
| 2024-03-04 | CTFR |
Final Rejection | 7 | View | |
| 2024-03-04 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2024-03-04 | FWCLM |
Index of Claims | 1 | View | |
| 2024-02-22 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | — | View | |
| 2024-02-22 | RCEX |
Request for Continued Examination (RCE) | 3 | View | |
| 2024-02-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-02-22 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2024-02-22 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2024-02-22 | CLM |
Claims | 3 | View | |
| 2024-02-22 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2024-02-22 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-02-22 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-08-22 | CTFR |
Final Rejection | 7 | View | |
| 2023-08-22 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2023-08-22 | FWCLM |
Index of Claims | 1 | View | |
| 2023-08-22 | OA.APPENDIX |
Office Action Appendix | 2 | View | |
| 2023-08-14 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2023-08-14 | XT/ |
Extension of Time | 1 | View | |
| 2023-08-14 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2023-08-14 | CLM |
Claims | 3 | View | |
| 2023-08-14 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2023-08-14 | DRW |
Drawings-only black and white line drawings | 2 | View | |
| 2023-08-14 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2023-08-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2023-08-14 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-02-14 | CTNF |
Non-Final Rejection | 8 | View | |
| 2023-02-14 | 892 |
List of references cited by examiner | 1 | View | |
| 2023-02-14 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2023-02-14 | FWCLM |
Index of Claims | 1 | View | |
| 2023-02-14 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2023-02-14 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2021-07-15 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2021-04-07 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-04-07 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-03-29 | DRW |
Drawings-only black and white line drawings | 5 | View | |
| 2021-03-29 | ADS |
Application Data Sheet | 8 | View | |
| 2021-03-29 | OATH |
Oath or Declaration filed | 2 | View | |
| 2021-03-29 | OATH |
Oath or Declaration filed | 2 | View | |
| 2021-03-29 | SPEC |
Specification | 28 | View | |
| 2021-03-29 | CLM |
Claims | 4 | View | |
| 2021-03-29 | ABST |
Abstract | 1 | View | |
| 2021-03-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-03-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Frederick J. Montgomery
Sun Prairie, WI
Duncan P. Bathe
Fitchburg, WI
Attorneys & Agents of Record
Classification
USPC
128/203.14
A61M16/12
A61M16/0003
A61M16/107
A61M16/201
A61M16/024
A61M16/0051
A61M16/04
A61M16/0666
A61M16/105
A61M2016/0015
A61M2016/0021
A61M2016/0027
A61M2016/003
A61M2016/0039
A61M2202/0233
A61M2202/0275
A61M2205/18
A61M2205/3334
A61M2205/50
A61M2205/75
Prosecution
- Examiner
- DOUGLAS, STEVEN O
- Art Unit
- 3612
- Customer No.
- 116219
- Docket No.
- H-IK-70002 US C13
- Confirmation No.
- 9729
Publication
- Pub. No.
- US20210213235A1
- Pub. Date
- 2021-07-15
Parent
is a Continuation of
→
App. 16/156,453
· US 10,960,169
Filed 2018-10-10
· Patented Case
Parent
is a Continuation of
→
App. 14/551,186
· US 10,099,029
Filed 2014-11-24
· Patented Case
Parent
is a Continuation of
→
App. 13/331,807
· US 8,893,717
Filed 2011-12-20
· Patented Case
Parent
is a Continuation in-part of
→
App. 12/430,220
· US 8,091,549
Filed 2009-04-27
· Patented Case
Parent
is a Continuation in-part of
→
App. 13/287,663
· US 8,517,015
Filed 2011-11-02
· Patented Case
Parent
is a Continuation of
→
App. 13/284,433
· US 8,397,721
Filed 2011-10-28
· Patented Case
Parent
is a Continuation of
→
App. 11/231,554
· US 7,523,752
Filed 2005-09-21
· Patented Case
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
RELEASE OF SECURITY INTEREST
Recorded 2025-08-14
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
SPECGX LLC,
OCERA THERAPEUTICS, INC.,
STRATATECH CORPORATION,
VTESSE LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
SUCAMPO PHARMA AMERICAS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536
Recorded 2023-11-16
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
MALLINCKRODT LLC,
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY
Recorded 2022-06-22
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2022-06-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/215,686
- Filed
- 2021-03-29
- Pub. No.
- US20210213235A1
- Examiner
- DOUGLAS, STEVEN O
- Art Unit
- 3612
External Links